AlbionVC has secured 3 nominations in GP. Bullhound Investor Allstars 2020 for venture capital fund of the year, exit of the year and Ed Lascelles, Partner at AlbionVC as investor of the year.
Odin Vision, a UCL Technology Fund portfolio company has received a grant to accelerate its cutting edge AI technology to fight bowel cancer. Odin Vision’s technology assists doctors to detect and characterise cancerous and pre-cancerous polyps during colonoscopy procedures.
Jay Wilson, Investment Manager at AlbionVC reflects on the impact of Covid-19 on M&A activity in fintech and discusses how his view has changed from the start of the pandemic to now. More on the story in FintechFutures.
uMotif Raises £5 Million Series A investment round led by us at AlbionVC to power decentralised clinical trials and get therapies to patients faster.
Pando, a messaging startup for doctors strikes a deal with the British Army to give thousands of troops deployed overseas access to medical expertise. Army medics have already sent more than 120,000 messages through the Pando app.
Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016.